Basics of New PHASE Reporting

Slides:



Advertisements
Similar presentations
Copyright © 2014 American Medical Group Foundation. All rights reserved. August 12, 2014 Initial Feedback Report: Hypertension Prevalence and Control.
Advertisements

0 LCH UDS REPORT UDS Demographics Characteristics % Change Total Patients2,5652, % Male % Females1,6801, % 0.
NAP Clinical and Financial Performance Measures Technical Assistance Call Overview of the Clinical Performance Measures September 23, 2010 Candace Kugel,
“2014 ACO GPRO Audit-What this means for your practice”
Azara Proprietary & Confidential Controlling High Blood Pressure 2014 Measure Changes Improving Patient Outcomes through Data.
Series 1: Meaningful Use for Behavioral Health Providers 9/2013 From the CIHS Video Series “Ten Minutes at a Time” Module 5: Clinical Quality Measures.
PBHCI Grantee Technical Assistance - Physical Health Indicator Data Jam Session Friday, February 11, :00 PM - 2:00 PM EST.
Life expectancy at birth SOURCE: CDC/NCHS, Health, United States, 2012, Figure 1. Data from the National Vital Statistics System.
Saeed A. Khan MD, MBA, FACP © CureMD Healthcare ACOs and Requirements for Reporting Quality Measures © CureMD Healthcare Saeed A. Khan MD, MBA, FACP.
Redwood Community Care Organization Data Capture for ACO Quality Measures.
 Maccabi is the second largest HMO in Israel. It covers 1.85 million people (24.5% 0f the population)  It is a recognized health fund within the framework.
Data Input Manual ACO Specific Quality Measures. Table of Contents Selection of Attributed ACO Patient…………………………………………………………...…….1 Section of Proper.
0 ICC Community CY 2013 Chart Audit September 9, 2014 Audit Timeframe: Jan 1, 2013 – Dec 31, 2013.
TRANSLATING VISITS INTO PATIENTS USING AMBULATORY VISIT DATA (Hypertensive patient case study) by Esther Hing, M.P.H. and Julia Holmes, Ph.D U.S. DEPARTMENT.
EXAM 1.A normal adult should have their BP checked at least how often? 2.What level of CVD risk over 10 years is considered high risk for primary prevention?
Oneida Community Health Nursing Department Disease Screening Form- updated 02/28/12 MLM Have you been screened for diabetes or high blood pressure beforeYESYESNO.
Tina Huang.  Aimed at people aged 40 – 74  Risk assessment and management programme to prevent or delay the onset of diabetes, heart and kidney disease.
Blood pressure control in primary health care WORKSHOP
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Use of Computerized Clinical Decision Support System and Registry Functions to Track and Improve Clinical Outcomes Pamela Ferrari RN Director of Performance.
Racial, genetic, life style influence: Type extent of complications (renal failure and stroke are more common in blacks). Response to dietary therapy (low.
Improving Hypertension Quality Measurement Using Electronic Health Records S Persell, AN Kho, JA Thompson, DW Baker Feinberg School of Medicine Northwestern.
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
Quality follow up programme in primary care. Experiences from Västra Götaland what have we learned? Staffan Björck, Analysenheten, Regionkansliet, Västra.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
C.Y UDS Reporting Enhancements For Reports Due on February 15, 2016 Bureau of Primary Health Care May 6, 2015.
Global Aim Assessment Theme Change Ideas Specific Aim Measures SDSA P DS A P D S A P DS A PDSA We are monitoring a list of 199 patients with.
ENSW PTO Training Clinical Quality Measures Kyle Knierim, MD Using DARTNet to Improve Practice Wilson Pace, MD Kyle Knierim, MD 1.
FY 2016 GPRA/GPRAMA update: CA Urban December 2015.
Monthly Metrics Forum February 2014 Appropriate Testing for Children With Pharyngitis And Appropriate Treatment for Children With Upper Respiratory Infection.
Free Powerpoint Templates Page 1 Using Data to Guide Improvement Presented by: Brooke Thomas, Program Advisor February 28, 2013.
RHP – 15 Diabetes Learning Collaborative Meeting
Screening System for Hypertension and Diabetes at Primary Care Level
Physical Health and People with a Severe Mental Illness
Dr John Cox Diabetes in Primary Care Conference Cork
If I Ran the Zoo: Quality Measures in Accountable Care and the Fit with Integrative Health and Medicine. Jim Whedon, DC, MS Research Working Group,
Redefining Quality Care in T2DM Patients with CV Disease
The Train Has Left the Station
Best Practice: Urgent Care PQRS.
Defining hypertension
At the end of this talk, the resident will be able to:
Chronic Disease Under Control: Diabetes and Hypertension
American Public Health Association Annual Meeting
Kaiser Permanente in the Community: Increasing Access to Care
PRACTICE MANAGER MEETING Wednesday Jan. 10th 2018 Noon – 1:00PM
High Blood Pressure (Hypertension)
Diabetes Health Status Report
Part 3 of 3 Welcome to this presentation on “Quality Measures in Cholesterol and Diabetes Management.” 1.
CDSS for Tobacco Screening and Follow-up Documentation
1422 Pre- Diabetes and Undiagnosed HTN Measures
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
Step Care Therapy for Hypertension in Diabetic Patients
DiRECT (Diabetes Remission Clinical Trial)
Fort Atkinson School District Wellness Program
Issues With Synthea Generated Patient Data for Use in Clinical Quality Measure – Hypertension Case Study Peter Li, OSEHRA 1/24/2019.
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Total number of screenings in 2016
Clinician Referral Training
Use Synthea Generated Patient Data for Clinical Quality Measure – Case Study: CMS165 Controlling High Blood Pressure Peter Li, OSEHRA 2/21/2019.
Uninsured and Underinsured Adults with Chronic Conditions Are More Likely to Visit the ER for Their Conditions Percent of adults ages 19–64 with at least.
Chronic Disease Under Control: Managed Care Plan Distribution, 2006
The Heart Truth Delaware Background
Behavioral Health Clinic Quality Measures (BHCQMs)
Gold Bar Performance Data CA Office of the Patient Advocate Report
CDM – Diabetes Billing.
Gold Bar Performance Data CA Office of the Patient Advocate Report
Gold Bar Performance Data CA Office of the Patient Advocate Report
Better Care at Lower Cost
Mean BP by visit - all patients
Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.
Presentation transcript:

Basics of New PHASE Reporting May 15, 2017 Redwood Community Health Coalition

PHASE Initiative Focuses on patients who have Abdominal Aortic Aneurysm, Coronary Artery Disease, Peripheral Artery Disease, Transient Ischemic Attack/Cerebrovascular Accident or Diabetes

PHASE Algorithm Medications Goals for: Blood pressure Statin HbA1c

2017 RCHC PHASE Reporting Data reported every quarter Measurement period Is one for the period of one year Previously, it was for a quarter For example, the measurement period for the quarter that just ended was 4/1/2016 to 3/21/2017

First Section: Patient Population Measures Old “REACH” section has been renamed “Patient population measures.” PHASE provides the ICD-10 codes for the reported patient populations

PHASE Reporting Patient Populations Report on the number of patients in defined populations who were seen at least once in the measurement period: Diabetes: patients aged 18-75 years with a diagnosis of diabetes and at least two primary care medical visits in the past two years ASCVD: patients aged 18 years and over with a diagnosis of ASCVD Hypertension: patients aged 18-85 years with a diagnosis of essential hypertension and diagnosed at least six months ago Unduplicated patients in these three populations

Second Section: Prescription Measures The medication measures were changed from all PHASE- eligible patients to patients with diabetes only Diabetes denominator is the same as the defined diabetes population (see last slide) except that the age rage is 55 to 75 years Diabetes prescriptions: statin and ACE/ARB NEW medication measure: patients in the hypertension denominator (see last slide) who have been prescribed an oral drug in the anti-hypertensive class

Anti-hypertensive Medications See the document “PHASE Clinical and Quality Measures: Oral Medication List for Hypertension” available from RCHC

Third Section: Screening and Follow-up The instructions give definitions for PRIME and UDS measures. Since most health centers are already familiar with the UDS measures, just report those Three UDS measures No change to definitions used by PHASE last year

Screening and Follow-up Measures Tobacco screening and follow-up. No change. BMI screening and follow-up. No change. Normal range: 2016 UDS Normal BMI: If aged 18-64 years, 18.5 ≤ BMI < 25; If aged 65+ years, 23 ≤ BMI < 30 2017 UDS Normal BMI: all ages 18+ years, 18.5 ≤ BMI < 25 Depression screening and follow-up. No change.

Fourth Section: Clinical Quality Measures Based on the defined populations of patients with diabetes and hypertension Diabetes controlled blood pressure (under 140/90 mmHg) Diabetes controlled A1c (under 9%) Hypertension controlled blood pressure (by what we call the “QIP” definition)

Diabetes Clinical Measures Take the last blood pressure and the last HbA1c in the measurement period If the denominator patient did not have a blood pressure or A1c in the measurement period, do NOT include him/her in the numerator Blood pressure numerator: < 140/90 mm Hg Blood sugar numerator: < 9%

Hypertension Clinical Measure Again, take the last blood pressure in the measurement period and if the patient did not have one, do NOT include him/her in the numerator Blood pressure numerator (the “QIP” definition): If < 60 years, BP < 140/90; If ≥ 60 years and has diabetes, BP < 140/90; If ≥ 60 years and does not have diabetes, BP < 150/90

Questions About PHASE?